HealthEquity (NASDAQ:HQY) EVP Sells $675,000.00 in Stock

HealthEquity, Inc. (NASDAQ:HQY) EVP Delano Ladd sold 7,500 shares of the firm’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the sale, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. This trade represents a 7.60% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

HealthEquity Stock Up 3.0%

Shares of NASDAQ HQY traded up $2.65 during midday trading on Monday, hitting $90.64. 1,399,147 shares of the company’s stock were exchanged, compared to its average volume of 1,017,490. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $116.65. The company has a market cap of $7.58 billion, a PE ratio of 33.95, a P/E/G ratio of 1.60 and a beta of 0.21. The firm’s fifty day simple moving average is $83.44 and its 200-day simple moving average is $86.67.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million for the quarter, compared to analyst estimates of $352.02 million. The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts predict that HealthEquity, Inc. will post 3.84 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have commented on HQY shares. KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. BTIG Research dropped their target price on HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a report on Tuesday, February 17th. BMO Capital Markets raised HealthEquity from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $85.00 to $105.00 in a report on Thursday, April 9th. Jefferies Financial Group set a $108.00 target price on HealthEquity in a report on Thursday, February 19th. Finally, Raymond James Financial set a $100.00 target price on HealthEquity in a report on Tuesday, February 17th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $111.53.

Institutional Trading of HealthEquity

Institutional investors have recently modified their holdings of the business. Acumen Wealth Advisors LLC purchased a new stake in shares of HealthEquity in the fourth quarter valued at approximately $27,000. Caitong International Asset Management Co. Ltd boosted its stake in shares of HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after buying an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in shares of HealthEquity in the fourth quarter valued at approximately $28,000. Leonteq Securities AG boosted its position in HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after purchasing an additional 235 shares in the last quarter. Finally, Axiom Investment Management LLC purchased a new stake in HealthEquity during the first quarter worth $33,000. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.